Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Sarepta Therapeutics (SRPT)

32.02 +1.87 (+6.20%)

2/24/2017  4:00pm

Open:

30.08

Pre. Close:

30.15

High:

32.09

Low:

29.70

Volume:

2,909,354

Market Cap:

1.75B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

32.69 - 33.33

33.33 - 34.59

Low:

28.15 - 28.61

28.61 - 29.53

Close:

30.99 - 31.93

31.93 - 33.78

Technical analysis  (as of: 2017-02-24 4:38:08 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 40.49     One year: 47.30

Support:

Support1: 29.47    Support2: 26.26

Resistance:

Resistance1: 34.67    Resistance2: 40.49

Pivot:

29.02

Moving Averages:

MA(5): 29.90     MA(20): 29.21

MA(100): 36.72     MA(250): 28.62

MACD:

MACD(12,26): -0.38     Signal(12,26,9): -0.81

%K %D:

%K(14,3): 88.31     %D(3): 72.91

RSI:

RSI(14): 59.34

52-Week:

High: 63.73  Low: 8.00  Change(%): 133.6

Average Vol(K):

3-Month: 2456  10-Days 2198

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SRPT has closed above the upper band by 16.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 61.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to SRPT's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 23 Feb 2017 17:48:45 GMT
Commit To Purchase Sarepta Therapeutics At $18, Earn 16.7% Using Options

Mon, 06 Feb 2017 21:00:00 GMT
Why Sarepta Therapeutics, Inc. Stock Rose 13.2% in January

Fri, 24 Feb 2017 14:37:30 GMT
Analysts Wary on Valeant Pharmaceuticals Intl Inc (VRX) as Salespeople Flee ...

Thu, 16 Feb 2017 12:33:45 GMT
Oppenheimer Stays Bullish on Sarepta Therapeutics Inc (SRPT) as the Stock ...

Fri, 24 Feb 2017 23:03:45 GMT
Sarepta Therapeutics Inc Risk Points versus Health Care

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

54.59

Shares Float (M)

47.57

% Held by Insiders

7.79

% Held by Institutions

61.20

Shares Short (K)

9170

Shares Short Prior Month (K)

9900

Stock Financials

EPS

-5.260

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

7.520

PEG Ratio

27.10

Profit Margin

Operating Margin

-19167.36

Return on Assets (ttm)

-44.7

Return on Equity (ttm)

-91.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.023

Sales Per Share

0.023

EBITDA (p.s.)

-4.302

Qtrly Earnings Growth

Operating Cash Flow (M)

-195.86

Levered Free Cash Flow (M)

-115.94

FoxReading.com

Valuation

P/E

-6.09

P/E Growth Ratio

0.06

P/BV

4.26

P/S

1398.38

P/CF

-8.92

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-07-12

Last Split Ratio

0.17

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.